Division of Molecular Medicine and Gene Therapy
171 – 180 of 620
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
BMP signaling is required for postnatal murine hematopoietic stem cell self-renewal
- Contribution to journal › Article
-
Mark
Restoring the immunogenicity of cancer cells with dendritic cell reprogramming
- Contribution to journal › Published meeting abstract
-
Mark
GATA2 at the mitosis-to-G1 transition is critical for definitive hematopoiesis
(2021) 2021 Virtual Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology: ISEH 50th Annual Meeting In Experimental Hematology 100(Suppl). p.35-35
- Contribution to journal › Published meeting abstract
-
Mark
Reprogramming Stars #4 : A Reprogramming Approach for Parkinson's Disease-An Interview with Dr. Malin Parmar
- Contribution to journal › Debate/Note/Editorial
-
Mark
Reprogramming Stars #3 : Mechanisms of iPSC Reprogramming-An Interview with Dr. Keisuke Kaji
- Contribution to journal › Debate/Note/Editorial
-
Mark
Compositions for reprogramming into dendritic cells type 2 competent for antigen presentation, methods and uses thereof
(2021) WO2021105234
- Patent › Patent
-
Mark
Compositions for reprogramming cells into plasmacytoid dendritic cells or interferon producing cells, methods and uses thereof
(2021) WO2021069672
- Patent › Patent
- 2020
-
Mark
Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency
- Contribution to journal › Article
-
Mark
Diamond Blackfan anemia is mediated by hyperactive Nemo-like kinase
- Contribution to journal › Article
-
Mark
Lysine-specific demethylase 1A (LSD1) restricts ex vivo propagation of human HSCs and is a target of UM171
- Contribution to journal › Article
